Kukje Pharma Co Ltd (002720) — Cash Flow-to-Debt Ratio
Kukje Pharma Co Ltd (002720) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of ₩4.99 Billion could theoretically repay 0% of its total liabilities (₩84.80 Billion) in one year. See 002720 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kukje Pharma Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Kukje Pharma Co Ltd across 14 annual periods. For the full cash flow conversion analysis, see 002720 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Kukje Pharma Co Ltd. Check Kukje Pharma Co Ltd (002720) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩3.94 Billion | ₩76.00 Billion | ▲ +13.6% |
| 2023 | 0.05x | ₩3.58 Billion | ₩78.31 Billion | ▼ -56.1% |
| 2022 | 0.10x | ₩6.50 Billion | ₩62.51 Billion | ▼ -22.8% |
| 2021 | 0.13x | ₩9.60 Billion | ₩71.20 Billion | ▲ +98.6% |
| 2020 | 0.07x | ₩5.10 Billion | ₩75.13 Billion | ▲ +38.7% |
| 2019 | 0.05x | ₩3.60 Billion | ₩73.64 Billion | ▼ -78.7% |
| 2018 | 0.23x | ₩13.25 Billion | ₩57.54 Billion | ▲ +1770.8% |
| 2017 | 0.01x | ₩786.10 Million | ₩63.87 Billion | ▼ -95.3% |
| 2016 | 0.26x | ₩16.10 Billion | ₩61.94 Billion | ▲ +448.9% |
| 2015 | -0.07x | ₩-5.08 Billion | ₩68.18 Billion | ▼ -8026.7% |
| 2014 | 0.00x | ₩-61.11 Million | ₩66.66 Billion | ▲ +98.8% |
| 2013 | -0.08x | ₩-4.60 Billion | ₩59.10 Billion | ▼ -393.2% |
| 2012 | 0.03x | ₩1.58 Billion | ₩59.57 Billion | ▼ -89.8% |
| 2011 | 0.26x | ₩17.39 Billion | ₩66.82 Billion | — |